首页 | 本学科首页   官方微博 | 高级检索  
     


The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand
Authors:L. K. Stamp  J. Haslett  C. Frampton  D. White  D. Gardner  S. Stebbings  G. Taylor  R. Grainger  R. Kumar  S. Kumar  T. Kain  D. Porter  M. Corkill  A. Cathro  S. Metcalfe  J. Wyeth  N. Dalbeth
Affiliation:1. Deparment of Medicine, University of Otago, Christchurch, New Zealand;2. Department of Rheumatology, Waikato Hospital, Hamilton, New Zealand;3. Department of Rheumatology, Hawkes Bay DHB, Napier, New Zealand;4. Department of Medicine, University of Otago, Dunedin, New Zealand;5. Department of Rheumatology, Whanganui Hospital, Whanganui, New Zealand;6. Department of Medicine, University of Otago, Wellington, New Zealand;7. Department of Rheumatology, Taranaki Hospital, New Plymouth, New Zealand;8. Department of Rheumatology, Middlemore Hospital, Auckland, New Zealand;9. Deparment of Rheumatology, Tauranga Hospital, Tauranga, New Zealand;10. Nelson Hospital, Nelson, New Zealand;11. North Shore Hospital, Auckland, New Zealand;12. Pharmaceutical Management Agency (PHARMAC), Wellington, New Zealand;13. Department of Medicine, University of Auckland, Auckland, New Zealand
Abstract:
Keywords:gout  benzbromarone  urate‐lowering therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号